ST Germain D J Co. Inc. Sells 233,254 Shares of CVS Health Co. (NYSE:CVS)

ST Germain D J Co. Inc. trimmed its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 93.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,359 shares of the pharmacy operator's stock after selling 233,254 shares during the quarter. ST Germain D J Co. Inc.'s holdings in CVS Health were worth $1,041,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. McIlrath & Eck LLC increased its holdings in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Coppell Advisory Solutions LLC boosted its position in shares of CVS Health by 17.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after buying an additional 189 shares during the last quarter. EagleClaw Capital Managment LLC grew its holdings in CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after buying an additional 200 shares in the last quarter. Manchester Capital Management LLC lifted its stake in CVS Health by 4.8% during the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock valued at $200,000 after acquiring an additional 204 shares in the last quarter. Finally, Angeles Investment Advisors LLC boosted its holdings in CVS Health by 3.7% during the 4th quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock worth $256,000 after acquiring an additional 204 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of CVS stock traded down $0.52 during trading on Thursday, reaching $63.05. 6,599,235 shares of the company's stock traded hands, compared to its average volume of 11,106,547. The firm's 50-day moving average is $65.39 and its 200 day moving average is $59.79. The company has a market capitalization of $79.76 billion, a P/E ratio of 17.23, a PEG ratio of 0.98 and a beta of 0.60. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same period in the previous year, the company posted $1.31 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.22%. CVS Health's payout ratio is presently 63.48%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Royal Bank of Canada lifted their price target on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Mizuho upped their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, Robert W. Baird lifted their target price on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Two analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.